All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0060 | Anti-C1orf50 (CBXC-1968) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1968 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3484 | Anti-C1orf50 (CBXC-1968) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1968 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2620 | Anti-C1ORF50 (CBFYC-0595) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Dog, Primate | CBFYC-0595 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5873 | Anti-C1ORF50 (CBFYC-0595) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Dog, Primate | CBFYC-0595 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0037 | Anti-C1orf50 (XHM69) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM69 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0038 | Anti-C1orf50 (XHM70) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM70 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0039 | Anti-C1orf50 (XHM71) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM71 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2329 | Anti-C1orf50 (XHM69) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM69 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2330 | Anti-C1orf50 (XHM70) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM70 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2331 | Anti-C1orf50 (XHM71) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM71 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION